Immunoassay Market Revenue to Cross $37.98 Billion, Globally, by 2027 - Exclusive Report by The Insight Partners
23 oct. 2023 10h43 HE
|
The Insight Partners
Pune, India, Oct. 23, 2023 (GLOBE NEWSWIRE) -- Immunoassays (IAs) are bio analytical technique in which the quantitation of the analyte relies on the reaction of an antigen and an antibody....
Global Antibody Discovery Services Market Set to Soar Past $1.6 Billion by 2023: Aiding Pharmaceutical Efficiency Through Outsourcing
18 oct. 2023 06h13 HE
|
Research and Markets
Dublin, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The "Antibody Discovery Market: Focus on Services and Platforms - Distribution by Type of Service Offered, Antibody Discovery Method, Type of Antibody...
United States Bispecific Antibodies Market & Clinical Pipeline Research Report 2023: Potential Market Opportunity of $15 Billion By 2028 - Dosage, Price and Sales Insights
16 oct. 2023 07h03 HE
|
Research and Markets
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- The "US Bispecific Antibodies Market & Clinical Pipeline Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's offering. The US...
Global Monoclonal Antibody Diagnostic Reagent Market Analysis Report 2023: An $18.63 Billion Industry by 2028 - ELISA Emerges as a Key Player
13 oct. 2023 05h18 HE
|
Research and Markets
Dublin, Oct. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Monoclonal Antibody Diagnostic Reagent Market: Analysis By Tests, By Application, By Region Size & Forecast with Impact Analysis of COVID-19...
Dyadic Appoints Doug Pace to Its Executive Leadership Team
09 oct. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 09, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic’s C1 Platform Selected by the Vaccine and Immunotherapy Center (“VIC”) at Massachusetts General Hospital as Part of VIC’s $5.88 Million Award by U.S. DoD to Develop a Self-Assembling Vaccine (SAV) Platform for Rapid Production of Prophylactic Vaccines for Infectious Diseases
05 oct. 2023 08h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building...
Dyadic to Present at Industry and Investor Events in October
29 sept. 2023 08h30 HE
|
Dyadic International, Inc.
Dyadic to Present at Industry and Investor Events in October
Mucous Membrane Decontamination Market revenue to surpass USD 15 Billion by 2035, says Research Nester
26 sept. 2023 05h00 HE
|
Research Nester
New York, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The global mucous membrane decontamination market size is slated to expand at ~15% CAGR between 2023 and 2035. The market is poised to garner a revenue...
Antibodies Industry Poised for Remarkable Growth as Therapeutic Applications Expand Worldwide
15 sept. 2023 09h43 HE
|
Research and Markets
Dublin, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The "Antibodies Market, By Drug Type, by Disease Indication By End User, And by Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030"...
Dyadic to Present at BioProcess International
12 sept. 2023 16h30 HE
|
Dyadic International, Inc.
JUPITER, Fla., Sept. 12, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building innovative microbial...